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Bullous conge~itai ichthyosiform erythroderma is a human 
hereditary skin disorder in which suprabasal keratinocytes 
rupture. Recent reports have implicated keratins K1 and K10 
in this disease. Here we describe four diverse keratin muta-
tions that are all significantly associated with this disease. 
Two of these are in the helix 1A subdomain of the type II 
keratin 1, giving a serine-to-proline substitution in codon 
185 and an asparagine-to-serine substitution in codon 187. In 
the analogous region of type I keratin 10, an arginine-to-pro-
Keratins are the major intermediate filament proteins found in the cytoskeleton of epithelial cells. These proteins assemble as coiled-coil heterodimers consist-ing o~ a specific type I (acidic) and type II (basic) keratin [1- 3] .. Dimers undergo further polymerisa-
tion t.o form keratin intermediate fil aments by an assembly process 
that has yet to be fully defined. Keratins are expressed as pairs in a 
tissue-specific manner. In the basal cells of epidermis in the skin, 
synthesis of keratins K5 (type II) and K14 (type I) predominate , 
w hereas in the outer suprabasallayers of the epidermis, keratins K1 
(type II) and K10 (type I) constitute the majority of the cellular 
protein. 
A direct role for keratins in maintaining the structural integrity of 
skin has recently been demonstrated by findings that certain point 
mutations in either of the K5 and K14 keratin genes are strongly 
associated with the autosomal dominant blistering disorder epider-
molysis bullosa simplex (EBS) , where blistering occurs through 
lysis of epidermal keratinocytes in the basal cell layer [4-6]. Simi-
larly, suprabasal splitting by cytolysis has been found to occur in 
BCIE [7,8], a dominant disorder characterised by pronounced hy-
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line and an arginine-to-serine transition in codon 156 have 
been identified. All four mutations create restriction frag-
ment length polymorphisms that were used exclude the mu-
tations from 120 normal chromosomes. Insertional poly-
morphism (in the V2 subdomains of the non-helical tails of 
K1 and K10) was excluded as the cause of the phenotypic 
heterogeneity observed within one family. Key words: EHK 
(epidermolytic hyperkeratosis) / intermediate filaments. ] Inllest 
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perkeratosis, ichthyosis, and erythroderma [9,10]. This condition is 
also referred to as epidermolytic hyperkeratosis (EH, EHK). Re-
cently, mutations associated with this disease have been reported in 
keratins 1 and 10 [11-13]. It has been shown by in vitro experiments 
that artificial mutations in these regions of keratins can affect the 
appearance of the filaments they form [14] . It is likely that ill vitlo the 
pathogenic keratin mutations compromise the resilience of the in-
tracellular supportive cytoskeleton of the keratinocytes, rendering 
them less resistant to physical trauma. 
In this study, we report mutations creating a serine-to-proline 
substitution and an asparagine-to-serine substitution in the helix IA 
subdomain of the keratin 1 polypeptide, seen in affected members of 
two fami lies carrying BCIE. Previously, all mutations found in the 
conserved 1A domain have been within type I keratins, and muta-
tions in type II keratins have all been in other domains (head HI , 
helix 2B). These are the first examples of mutations in the helix 1 
domain of a type II intermediate fil ament protein. We also report 
arginine-to-proline and arginine-to-serine mutations in helix 1A of 
keratin 10 rroducing the disease. These four diverse mutations in 
helix 1A 0 suprabasal epidermal keratins all produce severe BCIE 
phenotypes. Knowledge of where the mutation-sensitive points are 
in the proteins will help us to understand how keratin filaments are 
assembled and how they function, and will clarify the nature of 
these mechano-bullous diseases and lead to development of better 
treatment. 
MATERIALS AND METHODS 
Transmission Electron Microscopy Perilesional skin biopsy specimens 
were fixed in half-strength Karnovsky fixative, post-fixed in osmium te-
troxide, dehydrated in ethanol , and embedded in Epon, largely as described 
[8] but with additional ell bloc staining with uranyl acetate. Ultrathin sections 
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were further stained with uranyl acetate and lead citrate and examined in a 
Jeol 100CX electron microscope operating at 60-80 kV. 
lmmunoelectron Microscopy The specimens, derived from the same 
skin biopsy as the tissue used for transmission electron microscopy (above), 
were divided into subsamples no larger than 0.5 mm\ soaked for 1 h in 20% 
glycero l in phosphate-buffered saline (PBS) as a cryoprotectant, plunge-fro-
zen in liquid propane at -190·C using a Leica KF80 apparatus, subjected to 
freeze substitution in methanol using Leica CS-Auto apparatus, and embed-
ded in Lowicryl K11M resin [8). Ultrathin sections were collected on nickel 
grids and incubated with rabbit polyclonal antiserum to keratin 1 (RbaK1 
[15]). After extensive buffer washes, further incubations were performed 
using appropriate I-nm gold-conjugated secondary antibodies (Auroprobe 
One, Amersham International plc., Amersham, Bucks, UK). The gold parti-
cles were silver enhanced (IntenSE M, Amersham, UK) for easy recognition. 
Negative control studies included the use of normal rabbit serum instead of 
the specific primary antibody. 
Polymerase Chain Reaction (PCR) 
KeratilJ 1: A 578-bp genomic DNA fragment was amplified by primers 5' 
TIC CGG GTC TGG GTA CCG AAG 3' (designated K1pl, sense strand) 
and 5' CAC CTT TGT CAA TGA AGG AGG CAA 3' (K1p7, antisense 
strand) . Primer K1p1 is located at the start of the head domain coding 
sequence; Klp7 spans the exon1/intron1 junction in the lA domain. 
Keratin 10: A 590-bp genomic DNA fragment was amplified by primers 5' 
GAT ACA GCT CAA GCA AGC ACT ACT 3' (K10p14, sense strand, 
head domain) and 5' GTA GTA TIT GCT GTA GTC ACG AGG C3' 
(K10pll, antisense strand, linker L1 domain). 
PCR Conditio tiS: Approximately 500 ng of genomic DNA was used per 
100j.Li reaction containing 1.5 mM MgCI2, 0.2 mM each dNTP, 10% di-
methylsulfoxide, 0.5 Jig/ ml each primer, and 2.5 U Taq polymerase (Am-
plitaq). After an initial incubation at94 · C for 5 min, PCR was performed for 
30 cycles consisting of94·C for 30 seconds, 60 · C for 1 min, 72·C for 2 min 
on a DNA Thermal Cycler (Perkin Elmer Cetus, CAl· 
Cycle Sequencing PCR fragments were resolved on 1.5% low-
melting-point agarose gels and purified using Gelase (Epicentre, USA). Pu-
rified templates (50 fmol approximately) were sequenced using the DS-Cy-
cle sequencing system (BRL, Bethesda, MD) with [32P) end-labeled primer. 
The following PCR program was used for sequencing: 20 cycles consisting 
of94·C for 30 seconds, 55·C for 30 seconds, 72·C for 60 seconds, followed 
by 10 cycles of 94·C for 30 seconds, 72·C for 60 seconds. Samples were 
resolved on standard 6% denaturing sequencing gels. K 1 PCR fragments 
were sequenced initially with K1p7, and the reverse strand in the region of 
the mutation was also sequenced using K1p8 (5' TCT GCC CTC CTG 
GTG GCA TAC AAG 3') for confirmation. Similarly, K10 PCR fragments 
were sequenced using K10p11 in the first instance and the opposite strand 
sequenced with K10p7 (5 ' GGA GGA GAT GGT GGC CTT CTC TCT 
3') for confirmation of murations. 
Mutation Screening by Restriction Fragment Length 
Polymorphism (RFLP) 
Family 1: PCR was performed with primers K1p7 and K1p8 as described 
above with the following modifications. The PCR volume was reduced to 
50Jil. The PCR program consisted of an initial incubation at 94· C for 5 min, 
followed by 30 cycles consisting of 94·C for 30 seconds, 60·C for 30 
seconds, 72 ·C for 45 seconds. Following PCR, 10 Jil of 5 X MaeIII buffer 
and 1 U MaelII restriction enzyme (BCL) was added per 40 Jil PCR reaction 
mixture. After overnight digestion ar 55 ·C, samples were analyzed on 4% 
Nusieve agarose TBE minigels. The 159-bp PCR product amrlified from 
normal alleles contains two MaelII sites producing fragments 0 27,40, and 
92 bp. Digestion of the mutant allele yields fragments of 27 and 132 bp so 
that an additional 132 bp band was observed in affected heterozygotes. 
Family 2: PCR was performed using primers K1p20 (5' AGG TGA AGT 
CTCGAGAAAGGG 3') and Klp21 (5' CGTTCG CAAAACATCCTT 
TT 3') using the reaction conditions above with the following program: 
94·C for 30 seconds , 55·C for 1min, 72·C for 1 min, 30 cycles. Following 
PCR, 10 Jil 5 X DdeI buffer and 1 U DdeI was added per 40 Jil PCR reaction. 
After overnight incubation at 3rC, digests were analyzed as above. The 
193-bp fragment produced does not normally conrain a DdeI site. However, 
the mutation in this family produces a DdeI site 36 bp from one end; diges-
tion of the PCR product from the affected individual results in the appear-
ance of additional bands of 157 and 36 bp due to the mutant allele as well as 
the 193-bp band . 
Families 3 alld 4: PCR was performed using primers K10p11 and K10p24 
(5' GGC CTT CTC TCT GGA AA T GA 3') using the reaction conditions 
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Figure 1. Pedigrees of the four families under study, carrying bullous con-
genital ichth~osiform erythroderma (BClE) of Brocq. Closed symbols show 
affected mdlvlduals, opell symbols unaffected; squares represent male and circles, 
female. Crossed symbols represent deceased subjects. Arrow indicates the pro-
band. 
above wirh the following program: 94 · C for 30 seconds, 50 · C for 1 min, 
72·C for 1 min, 35 cycles. Following PCR, 5 Jil of 10 X AdI buffer was 
added to 45 Jil PCR product. Spermidine was added to a final concentration 
of 1 mM and the reaction heated to 65· C for 15 min before digestion with 2 
U AdI at 37· C for more than 2 h. Digests were analysed as above. Digestion 
of normal aJleles (195 bp) yields fragments of 59 and 136 bp. The mutations 
found in both fami lies 3 and 4 disrupt the A ciI site so that an undigested 195 
bp band is indicative of either mutation. 
Protein Structure Predictions The plots shown in Fig 6 show the re-
sults of analysis carried out on the complete amino acid sequence of helix 1A 
of human keratin 1 pins the a -helical portion of the H1 subdomain of the 
non-helical head region (residues 172-214 inclusive), using the Garnier 
algorithm of GeneWorks 2.1 (Intelligenetics Inc.) . The analogous region of 
K10 was also analyzed. PredIctIOns were based on calculations carried out 
using eight residues on either side of the target residue as recommended [16). 
V2 Domain Polymorphism in Keratins 1 and 10 The V2 subdomain 
of K 10 was amplified by PC R using the primers described elsewhere [17] 
with the following modifications. The thermal cycling program used was as 
described for Klp1 and K1p7 (above) and 10% dimethylsulfoxide was added 
to the reaction mix. Formamide and glycerol were omitted from the reac-
tion. The resulting reaction product was ana lyzed on 3% Nusieve TBE gels. 
The V2 subdomall1 of K1 was ampltfied as above with the following 
primers: Klp12 (sense strand) = 5' GTG AGC ACA AGC CACACCAGC 
3' and K1p13 (antisense strand) = 5' TTG TTA GTG ATG CTG GGG 
GAG 3' . The PCR fragments were visualized by end labeling of one primer 
and separation on a 6% sequencing gel. This reaction produced a 475-bp 
product from all members of the family ana lyzed. 
RESULTS 
Electron Microscopy A skin biopsy from an affected individual 
(the proband in pedigree 1 [Fig 1]) in a family carrying BCIE was 
examined by transmission electron microscopy (Fig 2). B listering 
was found to occur within the suprabasa l cell layers of the epider-
mis . Figure 2 illustrates the fil ament abnormali ties observed in this 
patient as pronounced aggregates in the granular (Fig 2a) and spi-
nous (Fig 2b) layers of the epidermis. Basal cells appeared normal. 
The diagnosis was therefore confirmed as BCIE, and distinguished 
from other ichthyoses or disorders causing hyperkeratosis. Figure 2a 
shows that much of the aggregated keratin forms a ring or sh ell 
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Figure 2. Transmission electron micrographs showi ng abnormal keratin 
tonofilamcnt aggregates in the granular (a) and spinous (b) layers of skin 
affected by epidermolytic (BCrE) hyperkeratosis. n) Instead of forming a 
normal network, the keratin filaments are tightly aggregated into wreath-
like distribution around the nucleus (N), or in discrete peripheral filament 
aggregates (FA). The cytoplasm has become vacuolated (V) where normal 
filaments are lacking. Scale bar, 1 fJ.m. b) Immunogold-silver enhanced label-
ing of Lowicryl Kl1M ultrathin section using a rabbit antiserum to keratin L 
Clear specific labeling is shown in a large keratin filament aggregate (open 
arrows) plus more peripheral aggregates, some of which are associated with 
intact desmosomes (D). Scale bar, 111m. 
around the nucleus, which is still separated from the nuclear enve-
lope by a thin rim of cytoplasm. Other material of different electron 
density is associated with this, probably other components of differ-
entiating keratinocytes. Filament clumps were shown to be selec-
tively stained with specific antisera to K1 and K10 by immunoelec-
tron microscopy (Fig 2b), implying the involvement of at least one 
of these cwo copolymerizing keratins in the disease. Very similar 
results were obtained for individuals from families 2 - 4 in this 
study. Figure 2b also demonstrates that desmosomes are still present 
and appear to be intact, and that some filamentous material is still 
attached to them. 
peR Sequencing 
Keratin 1 Sequence Corrections: Genomic DNA was extracted from 
skin fibroblast cu ltures and/or blood samples from four affected and 
one unaffected member of family 1 (Fig la) . Similarly, genomic 
DNA was obtained from the affected member and the unaffected 
individuals in family 2. 
A 578-bp fragment of genomic DNA comprising the coding 
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sequence for the VI and HI subdomains of the non-helical head 
region and most of the helix 1A domain of the rod region ofKl was 
amplified by PCR. Amplified DNA from affected and unaffected 
members of the family and unrelated normal individuals was se-
quenced directly by the cycle sequencing method. A number of 
sequence differences were observed, becween the sequence obtained 
from the normal controls and the previously published sequence 
[18], i.e ., C l08l (not T), CIl72 (not T), A1283 (not C), and A\288 (not 
C). Two of these changes alter the predicted amino acid sequence 
(Ser now becoming Pro l4 7 and Gin becoming LYSI84)' Protein se-
quence alignment comparisons show that these amjno acid alter-
ations increase the homology of Kl with the other type II keratins 
(not shown) and therefore have a probability of being correct. These 
changes were found to be consistent in six unrelated control samples \ 
and probably represent errors in the original sequencing of this gene 
as predicted [13J. They have been submitted to the genetic database 
of the European Molecular Biology Laboratory (EMBL), Heidel-
berg (accession number X69725) I 
Keratin 1 Mutations: By direct sequencing, all four affected mem-
bees of family I were found to be heterozygous for a T I286C transi-
tion in codon 185 of K1, which thus encoded a proline residue 
instead of the normal serine (Fig 3, EMBL accession number 
X69758) . The unaffected member did not have this mutation, nor 
was it present in six unrelated control sequences. The mutation was 
confirmed by sequencing of the reverse strand using an internal 
primer. The mutation occurs in the recognition site for the restric-
tion enzyme MaeII! thus allowing rapid screening for this mutation 
in the general population (Fig 4). No change in this site was ob-
served in 60 unrelated normal individuals, i.e., 120 separate alleles, 
indicating that this change is unlikely to be a polymorphism in the 
general population. 
The affected individual in family 2 was found to be heterozygous 
for a Al293G transition in codon 187 of K1, producing a asparagine 
to serine transition (Fig 3). The mutation was absent from the six 
unaffected members of the family . The base change in this family 
creates a new Dde1 site allowing screening for this mutation in the 
normal population. No additional site was observed in 60 unrelated 
normal individuals (Fig 4) . 
The positions of these mutations, together with two other muta-
tions in K1 previously reported to be present in patients with BCrn 
[11 - 13], are shown in Fig 5 relative to the consensus domain struc-
ture of keratin polypeptides. Like the mutations in K5 and K14 that 
cause the analogous disease EBS, and those reported in KlO causing 
BeIE, the mutations appear to cluster in two highly conserved 
regions around i) the start (in HI, 1A) and Ii) the end (helix tenni-
nation peptide) of the a-helical rod domain, with the exception of 
one mutation in helix 2B ofK14 reported to cause a Koebner form 
of EBS [5). This is consistent with transfection experim.ents [19 ,20J 
and il1 vitro filament assembly studies [21 ,14] with keratins carrying 
deletions and point mutations in the ends ohhe rod domain, which 
indicate that these regions are essential for normal polymerization. 
The mutations reported here occur close to the start of the rod 
domain, although the altered S185 residue is not so highly conserved 
as those previously observed to be mutated. In contrast, the mutated 
N 187 residue in family 2 is very highly conserved between all type I, 
II, and III intermediate filament proteins, thus one would expect 
mutations here to have some effect. 
Keratin 10 Mutations: A 590-bp fragm.ent of the KI0 gene was 
amplified by PCR. This fragment includes most of the head do-
main, helix lA and linker Ll. This was directly sequenced with the 
reverse primer initially used for amplilication and the mutations 
were confirmed by sequencing of the sense strand with an internal 
primer. 
The affected individual in family 3 was found to be heterozygous 
for a point mutation G2I4oC that produces an arginine-to-proline 
substitution in codon 156 at the start of the helix 1 A domain of Kl 0 
(Fig 3). Similarly, the affected individual in family 4 was found to 
have a point mutation C2139A that changes arginine to serine in the 
same codon of KlO (Fig 3). The unaffected parents in both these 
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Individual 112 
Primer K1 p7 
Family 2 
Individual lis 
Primer K1 p8 
Family 3 
Individual 114 
Primer K10p7 
Family 4 
Individual 111 
Primer K1 0p7 
a 
-» 
BCIE 
GAT C 
CONTROL 
GAT C 
Normal Kl 
Family 1 
Family 2 
Normal KIO 
Family 3 
Family 4 
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Helix 1A 
1271 Mae III 1303 
AGG GAG CAA ATC AA~TC M C AAC CM TTT 
R E Q I K S L N N Q F 
AGG GAG CAA ATC MG eCA CTC M C MC CM TTT 
R E Q I K P L N N Q F 
DdeI 
AGG GAG CM ATC AAG CCA ~C MC CM TTT 
R E Q I K S L S N Q F 
Helix lA 
2112 AclI 2144 
AM GTA ACe ATG e AG AAT eTG AAT GA~ eTG 
K v T M Q N L N D R L 
AM GTA ACe ATG eAG AAT eTG AAT GAC c e e eTG 
K v T M Q N L N D P L 
AM GTA ACe ATG CAG AAT CTG MT GAe AGC eTG 
K v T M Q N L N D S L 
Figure 3. Identification of mutations in keratins 1 and 10. a) Excerpts from sequencing gels of DNA amplified from affected members (lift tracks, BCIE) in the 
four families under study, compared with DNA samples derived from four separate unaffected unrelated controls (right tracks, control). Termination bases in 
each track are indicated above (G, A, T, C). Sequences shown from fami lies 1 and 2 ate from the gene encoding keratin I , and those for families 3 and 4 are from 
the keratin 10 gene. Marks indicate positions of mutations. Primers Kl p7, Kl p8, and KI0p7 used for sequencing reactions are as described in the Materials a"d 
Methods section. Note that the K 1 p7 sequences are from the non-coding strand and the gel has been reversed for ease of reading. b) Genomic DNA sequences in 
the helix lA domains ofKl and KI0 as read from a longer region of the above gels, and the predicted amino acid sequences (single letter nomenclature below 
each DNA codon). Bases numbers 1271-1303 ofKl and 2112-2144 ofK10 are shown. Bold type indicates mutated bases and amino acids. The recognition 
sequences of restriction endonucleases affected by the various mutations as used for population screening are underlined. 
families had no alterations in this region by direct sequencing or 
PCR screening. 
Both mutations observed in families 3 and 4 disrupt a recognition 
site for the restriction enzyme Ad!. A PCR-based Ad! RFLP assay 
was used to screen unaffected members of both families and a popu-
lation of 60 unrelated, unaffected individuals. An additional band 
was only seen in PCRs from the two affected individuals (Fig 4). 
The positions of these and previously reported mutations [11-13] 
within the protein are shown in Fig 5. The affected residue RI56 is 
completely conserved within the type I and type III intermediate 
filament proteins and thus a point mutation at this position is likely 
to be detrimental to the assembly and/or structural integrity of 
keratin intermediate filaments. 
Effects of Mutations on Predicted Protein Structure 
Substitutions in Kerati" 1: At position 185 of human Kl there is a 
serine residue. Most human type II keratins have threonine at this 
position, although this residue is leucine in human K4 and alanine 
in human K7. Analyses of this domain according to the Garnier 
method [16] predict a tendency to form a-helix. In comparison, a 
proline substitution at residue 185 would cause a major disruption of 
the helix according to Garnier predictions (Fig 6), consistent with 
the helix forming values of [22,23]. Interestingly, the threonine 
alternative observed at this position in most type II keratins increases 
the predicted helicity slightly, and the natural sequences observed in 
K4 and K7 both give a considerably stronger prediction of a-heli-
city (plots not shown). Subtle variations such as this between kera-
tins may reflect their individual tissue-specific functional require-
ments. 
By contrast, the Kl N t87S mutation observed in family 2 is a 
relatively conservative transition because both serine and asparagine 
are uncharged under physiologic conditions. Asparagine, however, 
has a slightly larger side chain. Garnier prediction for this mutation 
in the 1A domain of K 1 indicates that the tendency to form part of 
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Figure 4. Screening for tbe BerE mutation by restriction fragment length 
polymorphism analysis. Tracks number from left to right. a) peR amplifi-
cation a 132-bp fragment of human keratin 1 from genomic DNA. Track 1, 
DNA ladder (BRL, type VI). T he smallest fragment is 154 bp. Track 2, pe R 
water control. Track 3, proband from Bern family 1; track 4, unaffected 
family member; tracks 5-14, normal umelated control samples. The muta-
tion destroys a recognition site for the restriction endonuclease MaeIII and 
therefore creates a restriction fragment length polymorphism. The occur-
rence of the mutation in PeR-amplified DNA is revealed by the presence of 
an additional large undiges ted 132-bp band fo llowing digestion with Mae/II. 
An additional band was observed in all five affected members of the family 
under study, and was not seen in samples from 60 normal umelated individ-
uals. b) peR amplification a 193-bp fragment of human keratin 1 from 
genomic DNA. Track 1, DNA ladder. Track 2, peR water controJ. Track 3, 
proband from family 2. Tracks 4- 13, normal unrelated control samples. 
The affected individual has an additional smaller 157 bp band following 
digestion with the restriction enzyme DdeI, as the mutation in this case 
creates a new DdeI site not present in the controls. c) peR amplification a 
195-bp fragment of human keratin 10 from genomic DNA and digestion 
with Ad!. Track 1, DNA ladder. Track 2, peR water control. Tracks 3 and 
4, probands from families 3 and 4, respectively. Tracks 5-14, normal ume-
lated control samples. Normal control samples are digested to give 59- and 
136-bp fragments. The fragments amplified from affected heterozygous 
individuals have an additional uncut band because either mutation disrupts 
this site. 
an a -helix is unchanged. Interestingly, the phenotype of the patient 
carrying this mutation is severe and very similar to that observed to 
that of patients in family 1 carrying the S!8SP mutation. It appears 
therefore that it is not m.erely the a-helical conformation of this part 
of the lA dotnain that is necessary for the correct function ofKl/l0 
intermediate filaments, but that residues in this region are involved 
in other important interactions. This is consistent with current 
thinking on the higher-order filament assembly of keratin dimers, 
where there is evidence for an overlap of about 10 amino acids 
between the ends of rod domains in the assembled fil aments [24] . 
Substitutions in Keratin 10 The K10 mutations observed in 
families 3 and 4 produce similar Garnier predictions to that obtained 
for the K1 mutations above (Fig 6) . The R 156P mutation is again 
predicted to be high ly disruptive to the a-helical conformation of 
this domain, whereas the R! S6S mutation is much less damaging to 
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the predicted a-helix formation. In this case , a positively charged 
side chain is replaced by a polar, non-charged side chain so one 
might expect this to adversely affect the formation of dimers or 
higher-order structures . 
The mutations seen here to cause BClE therefore demonstrate 
the importance of the a-helical lA rod domain in maintaining the 
structural and functi onal integrity of keratin intermediate filam"ents 
in differentiated epidermal cells. Substitution of a helix-breaking 
amino acid seriously disrupts the conformation of this functional 
domain and leads to a disease phenotype in two cases. In two other 
instances, although the mutation is apparently less damaging to 
a -helix conformation, aberrant keratin filaments are observed his-
tologically and the disease phenotype is similar. This demonstrates 
that the precise amino acid sequence of this part of the 1 A domain of 
Kl and K10 is vital for production of functionally correct filaments 
and underlines the probable role of these conserved regions in 
higher-order filament assembly [24]. 
Phenotypic Variation and V2 Domain Polymorphism An 
aspect of BClE that has yet to be addressed is the findin g that the 
clinical phenotype can vary greatly within famili es, and also with 
the age of the patient. Both these forms of variation are found in 
family 1 reported here. The affected individual in generation II (Fig 
7) was very severely affected in childhood, with t!le majority of the 
skin hyperkeratotic. The severity has markedly decreased with age 
(patient is now in her mid 40s) and now only the hands, feet, and 
some flexor surfaces are affected. The patient does not use any 
medication. Patient III! has an similar phenotype, whereas patients 
lII2 and IlIJ have very mild and localized changes . The occurrence 
of severe and mild phenotype in family 1 is indicated as S or M, 
respectively, in Fig 7. 
These findings are interesting because each of these patients are 
shown here to carry the identical mutation in K 1. We have made 
similar observations within other BC IE kindreds (not shown here). 
It is possible that an otherwise benign polymorphism, either in 
keratins or in th eir associated accessory proteins, may have a modi-
fying affect on the expression of the phenotype. The effect is un-
likely to be due to mosaicism, as the lesions are not obviously focal 
even in the proband, who is already at least the second generation to 
be affected. Insertional polymorphism is known to occur in the 
variable non-helical head and tai l domains ofK1 and KI0 [16 ,25]' 
Recent studies imply that although these end domains may not be 
essential for fil ament assembly, th ey are probably involved in main-
taining the stability of 10 nm intermediate filament network 
[26,27]. Because the V1 and V2 domains are the regions that vary 
most between keratins, these domains are thought to influence the 
qualities of the fil aments required in specific tissues, such as strength 
or flexibility. Insertional polymorphism of this type might there-
fore be involved in phenotypic variation within BCIE. T o test this , 
the V2 domains of Kl and K10 were amplified by peR from ge-
nomic DNA taken from all members of the family . No size varia-
tioll was observed in the V2 domain of Kl in the family, with all 
members being homozygous. 
Insertional polymorphism, however, was observed in the KI0 V2 
domain, where two alleles differing by approximately 75 bp were 
seen, representing an insertion of about 25 am.ino acids. However, 
variation in the severity of the phenotype clearly does not segregate 
with this polymorphism, as shown in Fig 7 . 
DISCUSSION 
The patients in the families under study expressed the hallmarks of 
BCIE, the occurrence of blistering and keratin tonofilament aggre-
gation within the suprabasal layers of epidermis. Immunoelectron 
microscopy showed that Kl and KIO were prominent components 
of the filament clumps. DNA sequencing revealed underlying ge-
netic defects in the IA domain of keratins 1 and 10. In Kl these were 
S!8SP and N!87S; in K10 mutations R! S6P and R!S6S were found. 
These mutations are not present in the normal population. DNA 
encoding the ends of the rod domains ofKl and KI0 have now been 
seguenced from 10 families with BCIE in this laboratory; only these 
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Figure 5. Schematic diagram of human keratins 1 and 10 showing consensus protein domain structure and the positions of mutations reported here in BCIE 
patients both here (shown above protein diagram) and by other groups (shown below protein diagram). 
four families show mutations in these regions. It is supposed that the 
genetic defects in the other six kindreds lie elsewhere in these kera-
tins, or in other epidermal differentiation keratins such as K2e, or in 
a non-keratin gene(s). 
The importance of the helix lA domain in assembl y and/or in-
tegrity of the Kl / KIO fil ament networks in suprabasal keratino-
cytes is demonstrated by these mutations, which are analogous to 
the K5/ K14 dependence on the same domain for filament integrity 
in the basal cells in EBS. The early appearance of reciprocal cluster-
ing of mutations at the start of the type I rod domain and at the end 
of the type II rod domain was probably due to small sample num-
bers; it is now known that mutations at either end of the central rod 
domain of either a type I or type II keratin can cause blistering 
disorders. It seems probable that EBS-causing mutations will also be 
found at the start of helix lA of K5 . To date there have been no 
mutations found in the helix termination peptide of a type I keratin . 
Whether this is because such mutations are non-pathologic, or are 
lethal, or whether this apparent bias is sti ll due to small sample size 
remains to be seen. 
Although the mutation Kl SI8SP observed here is not in as highly 
a conserved residue as those reported previously, the transition from 
serine to proline in this a-helical domain is predicted to be highly 
disruptive. It appears that the IA domain must exist in an a-helical 
conformation or the cytoskeletal properties of the filament network 
are significantly compromised. Whether the defects interfere with 
nucleation, elongation, or higher-order filament assembly is U11-
clear. 
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Figure 6. Garnier a-hel icity plots of normal keratin 1 (left) and keratin 10 
(right) helix lA domains and the four mutant keratins described here. Pro-
line is seen to cause severe disruption of the a-helix in either protein; how-
ever, the Kl N IB7S and the KI0 R, s6S mutations have comparatively mild 
effects on the predicted helicity c r this region. 
In contrast, the N 187S occurs in a res idue that is conserved be-
tween all type I, II, and III intermediate filam ent proteins character-
ized thus far. The transition from asparagine to serine is semi-con-
servative, both amino acids having uncharged polar side chains. 
However, this mutation nevertheless produces a clinical phenotype 
that is as severe as those observed with proline substitutions demon-
strating that even slight changes in this highly conserved region of 
the lA domain calmot be tolerated for functional fil ament forma-
tion. 
The KlO mutations reported here both affect the conserved resi-
due RI56 in the lA domain. The mutation RIS6H in KIO has been 
previously reported to be linked to BCIE/EHK, and the analogous 
arginine (R125) ofK14 has also been found to be mutated to histidine 
or cysteine in patients with the Dowling-Meara form of EBS. Of all 
the keratin mutations identified to date in mechano-bullous diseases 
of which we have information, at leas t 14 of 32 affect exactly this 
arginine residue, so it is not surprising to find two more in the four 
mutations we document here. The DNA motif CpG, in w hich the 
C is often methylated in mammalian coding sequences, occurs in 
Phenotypic variation unrelated to size 
variation In the V2 domain of keratin 10 
II 
III 
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Figure 7. Pedigree showing the occurrence of severe (S) or mild (M) phe-
notype within BCIE family 1 under study. Results of PCR analysis of the 
polymorphic V2 domain of keratin 10 are shown. Allele 1 is approximately 
525 bp; allele 2 is approximately 450 bp. A tandem repeat (essentially GGC 
repeating units) occurs in the coding sequence and thus the gene product of 
allele 1 has an additional 25 amino acids (approximately) in the tail domain. 
However, this extended tail domain is seen to be unrelated to the observed 
phenotypes. 
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this arginine codon in both KIO and K14. Methyl-C can be sponta-
neously deaminated to become T, resulting in C-T (or G-A muta-
tions). The arginine-to-histidine and arginine-to-cysteine muta-
tions reported represent the two possible products of deamination of 
the methyl-C on the antisense and sense strands, respectively. The 
two mutations described here in this codon involve C-A and G-C 
transitions and therefore CpG deamination events are not the only 
cause ofBCIE mutations in this codon, although these are probably 
more common. This residue is very highly conserved in the type I 
kerat ins and the range of mutations seen so far in this codon in the 
I A domain show that a variety of amino acid substitutions are dele-
terious to the ;11 vivo function of the Kl/I0 cytoskeleton. 
Taken together, the mutations reported here in KI and KIO 
emphasise the importance of the lA domain in the function of 
keratin intermediate filaments. It is interesting to note that all the 
helix lA mutations found thus far that are associated with filament 
aggregation and severe clinical phenotype are clustered near the 
start of the rod domain. The only mutation seen at the internal end 
of this domain (E144A in K14) produces a very mild recessive EBS 
phenotype despite being a non-conservative amino acid substitution 
l28]. Heterozygous individuals in that particular family showed no 
clinical features of the disease. There is a marked difference in the 
degree of conservation observed between the amino-terminal start 
of lA (which is highly conserved between the various keratins) and 
the carboxyl-terminal end of the domain (which is only moderately 
conserved). Although the sample number is still small, there would 
appear to be a broad correlation between disease severity and the 
position of the mutation within helix lA. This in turn correlates 
well with data suggesting that the first 10 or so residues of lA are 
involved in overlap interactions between dimers in the assembly of 
keratin filament structures [24]. From this, one would predict that 
mutation in these residues (or close by) would have much more 
serious effects on filament formation than mutations near the car-
boxy-terminal terminal end of helix lA. This is supported by all the 
mutations reported to pate. 
The possible role of known polymorph isms in V2 domains ofKl 
and KI0 in the marked phenotypic variation exhibited in this family 
was investigated, but results failed to indicate any relationship be-
tween size of these domains and phenotypic heterogeneity. Genetic 
linkage analysis of a large kindred with highly polymorphic DNA 
markers may reveal the involvement of non-keratin genes encoding 
accessory proteins in this phenomenon. Data have been reported 
that suggest linkage of the rare Ogna form of EBS to loci on cllfo-
mosome 8 [29]. Because all keratin genes cloned to date have been 
found to map to gene clusters on chromosomes 12q and 17q, it 
seems possible that a non-keratin gene may be involved in this 
disorder. Genes for keratin-associated or regulatory proteins may 
playa hitherto unrecognized role in keratin filament assembly, 
structural integrity of the cytoskeleton or in phenotypic variation of 
these diseases. Identification and characterization of more accessory 
proteins may be essential to gain complete understanding of keratin 
filament biology. 
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